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Background: Recently, questions have been raised regarding the ability of animal models to recapitulate human
disease at the molecular level. It has also been demonstrated that cellular kinases, individually or as a collective unit
(the kinome), play critical roles in regulating complex biology. Despite the intimate relationship between kinases
and health, little is known about the variability, consistency and stability of kinome profiles across species and
individuals.
Results: As a preliminary investigation of the existence of species- and individual-specific kinotypes (kinome signatures),
peptide arrays were employed for the analysis of peripheral blood mononuclear cells collected weekly from human and
porcine subjects (n = 6) over a one month period. The data revealed strong evidence for species-specific signalling
profiles. Both humans and pigs also exhibited evidence for individual-specific kinome profiles that were independent
of natural changes in blood cell populations.
Conclusions: Species-specific kinotypes could have applications in disease research by facilitating the selection of
appropriate animal models or by revealing a baseline kinomic signature to which treatment-induced profiles could
be compared. Similarly, individual-specific kinotypes could have implications in personalized medicine, where the
identification of molecular patterns or signatures within the kinome may depend on both the levels of kinome
diversity and temporal stability across individuals.Background
Efforts to increase our understanding of the mechanisms
of human disease from the perspectives of both gross
pathology and molecular pathogenesis have relied heavily
on the use of animal models that are assumed to mimic
those pathological states. Animal models, in particular
those involving mice, have been employed extensively
in such investigations as well as for identifying novel
therapeutics and assessing their efficacy. However, many
studies have relied on the similarities in the phenotypic
presentation of disease rather than similarities in the
underlying molecular mechanisms. Further confounding
these investigations has been the assumed cross-species
conservation in identities and physicochemical properties
of the host molecular machinery. Although murine models
have been employed extensively, there has been a relative* Correspondence: scott.napper@usask.ca
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reproduction in any medium, provided the orpaucity of therapeutic candidates that have translated
into approved use for humans. These observations have
resulted in extensive debate regarding the ability of many
animal models to faithfully recapitulate human disease
and to accurately predict drug efficacy in humans.
Given this, it would seem prudent to re-evaluate the
criteria that drive the selection of a particular species as
an animal model. Seok and colleagues recently reported
that the genomic responses of mice in acute inflammatory
disease models correlated poorly with those of human
patients [1]. Although the authors recognized that these
prior studies may have been hindered by inadequate
study designs, a fatal flaw for many investigations can
likely be attributed to the assumption of conservation of
host responses between mice and humans. In light of these
findings, it has been suggested that a practical solution
would be to select animal models based on their conserva-
tion of molecular responses to those of humans. Further,
for diseases in which human clinical studies are not ethical,
selection of animal models that best reflect or mimic
human molecular responses would provide increasedd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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This highlights the need for novel approaches to assess
the conservation in molecular responses and identify
conserved biomarkers between humans and non-human
animals used in disease models.
Analyzing the conservation of molecular responses has
applications not only in selecting appropriate animal
models, but also in biomarker identification. While the
identification and characterization of biomarkers related
to disease pathology has resulted in their application to
guide the diagnosis and treatment of disease [2,3], the
clinical value of such biomarkers in enabling effective
diagnosis or treatment guidance is dependent upon their
sensitivity and specificity, which are often low [4,5].
Historically, biomarkers have typically represented varia-
tions in the sequence, expression or modification of a single
biomolecule. While such a simple relationship between a
molecular characteristic and a phenotype is attractive from
conceptual and practical perspectives, it underestimates
the complexity associated with many diseases. Although
some diseases are attributable to a single gene, these
binary diseases represent the “low hanging fruit” of
biomarker discovery. Further, in many cases diseases
considered to be genetically determined have been found
to display variability that must be attributed to other
regulatory or phenotypic differences between individuals.
Therefore, it seems appropriate to move beyond the
“single gene, single disease” paradigm to a more systematic
understanding of health and disease. This shift to more
direct phenotypic determinants of disease often requires
characterizing molecular mechanisms and biomarkers
at informative, global levels. Such a systems biology
approach requires examination of the dynamic interplay
between large collections of biomolecules. A key challenge
for the identification of biomarkers for such multi-faceted
phenotypes is the development of technologies that effect-
ively reflect these complex interactions in patient-derived
samples. Investigations of dynamic patterns of gene and
protein expression, through transcriptional and proteomic
approaches, have offered insight into a number of disease-
associated phenotypes. In cancer, for example, there are
a number of biomarkers that contribute to diagnosis,
subtype classification, prognosis and treatment outcomes
[6]. Similarly, in hepatitis C virus (HCV) infection, patterns
of expression of interferon (IFN)-related genes predict IFN
treatment efficacy [7]. While these examples highlight the
potential to apply global approaches to understand biology
and identify biomarkers, there is concern regarding the
inability of these approaches to consider post-transcriptional
and post-translational regulatory events.
Kinase-mediated phosphorylation is the predominant
mechanism for regulation of protein function. Disruption
or dysregulation of kinase activity is associated with a
number of pathophysiological states, including cancer,inflammation, neurological disorders and diabetes [8].
Thus, there is considerable interest in defining kinase
activities, as well as in manipulating them for therapeutic
purposes—an objective facilitated by the fact that kinases
are highly “druggable” [8]. As a result, kinases represent
a top priority of the pharmaceutical industry [9] and are
currently the most frequently targeted gene class for cancer
therapies, second only to G protein-coupled receptors
across all therapeutic areas [10]. Increased appreciation
for the intimate link between kinases and health has
prompted the development of technologies to characterize
the phosphoproteome or kinome [11], including efforts
by our group to utilize peptide arrays for low-cost, high-
throughput kinomic characterizations [12-16].
With respect to protein phosphorylation, the simplest
evidence for the conservation (or lack thereof) of molecu-
lar responses among species lies in the content of the
kinome. Genome sequencing has revealed that eukaryotes
differ greatly in the number of protein kinases encoded by
their genomes. For instance, the human genome encodes
approximately 518 protein kinases [17]; in contrast,
the proteome of Arabidopsis thaliana encodes around
1000 protein kinases [18], while Saccharomyces cerevisiae
encodes fewer than 120 [19]. This suggests that kinase-
mediated molecular responses may not be well-conserved
among species, and that conclusions drawn from the
investigation of protein phosphorylation in one species
may not be applicable to another species. On the other
hand, a previous study using peptide arrays suggested that
despite the very different protein kinase complements in
various eukaryotes, the substrates phosphorylated by these
organisms exhibit substantial similarities [20]. As such,
the level of conservation of kinase-mediated host responses
in different species has yet to be fully delineated.
In outbred animals, it is common to observe a range
of responses to a given stimulus or condition. This diversity
likely reflects a combination of genetic, environmental
and situational variables. Similar diversity is also apparent
within human populations. In our previous investigations
of livestock, unique animal-specific patterns of baseline
kinome activities were often observed [12,13]. From these
animal-specific baselines, conserved yet variable responses
to defined stimuli were found, suggesting that phenotypes
are represented within unique cellular kinome environ-
ments. Given the close relationship between kinases and
phenotype, we hypothesized that these unique signaling
patterns could be used as biomarkers.
To probe the existence of species- and individual-specific
kinotypes, we applied peptide arrays to conduct kinome
analysis of human and porcine peripheral blood mono-
nuclear cells (PBMCs). The peptides on the array represent
phosphorylation events for which there is perfect sequence
conservation between human and pig, making this array
equally applicable for investigating either species. For each
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week for four consecutive weeks. The extent of conserva-
tion of kinome activity was evaluated through hierarchical
clustering analysis, principal component analysis (PCA),
and statistical consideration of the data. Across humans
and pigs, there was overwhelming evidence for species-
specific kinome profiles. The human subjects, who were
variable in terms of age, gender, genetics and lifestyle,
also provided evidence for individualized, stable kinome
profiles. Similarly, a distinctive kinotype was observed
among pigs, where potential sources of variability like age,
genetics and lifestyle were minimized. The demonstration
of species-specific kinotypes may have applications in the
selection of animal models for certain diseases, while
the existence of stable, individualized kinotypes within
members of the same species may have utility in using
phosphorylation-associated biomarkers to guide disease
diagnosis and treatment.
Results
Raw and normalized array data
For each species (human and pig), one sample was taken
from each of six individuals for four consecutive weeks,
for a total of 48 samples. Peptide arrays were incubated
with each sample, and raw phosphorylation intensity data
were collected by scanning the arrays and determining the
intensity of each spot (the foreground intensity), as
well as the intensity of the slide surrounding that spot
(the background intensity). Because the stain binds
non-specifically to the slide itself, the background in-
tensity was often greater than the foreground intensity;
in fact, only 14% of spots from the human arrays and
31% of spots from the porcine arrays had a raw foreground
signal greater than the corresponding background signal.
There were also differences among subjects from the same
species in terms of the number of spots having a fore-
ground signal above background. However, these systemic
variations were eliminated once normalization was per-
formed using VSN. Specifically, the average signal intensity
(after background subtraction and normalization) among
spots from the human arrays was 11.77 compared to 11.81
for the pig arrays, showing that measurements from the
different arrays had successfully been brought onto the
same scale. The raw and normalized intensity data for
all arrays are available as Additional file 1 and Additional
file 2, respectively.
In order to evaluate the technical reproducibility of
the arrays, individual peptides (297) were printed nine
times per array, and a chi-square test was performed
for each unique peptide on a given array to determine the
variability amongst these technical replicates. Peptides with
P-values <0.01 were designated as inconsistently phosphor-
ylated on that array. Over all 48 arrays, an average of 282
peptides yielded technically reproducible signals within anarray (range: 268–296), giving strong evidence for the
technical reproducibility of the phosphorylation signal.
Due to this strong reproducibility, all 297 peptides were
used for subsequent analyses.
Species-specific kinome profiles
Species-specific variations in phosphorylation-mediated
signalling were considered as the initial test for the ex-
istence of kinotypes. Pigs were selected for comparison
because they are often employed in large animal models of
human diseases and therapeutic studies due to conserved
biological responses and significant genetic similarities
[21,22]. PBMCs were used as they are obtained through
non-invasive procedures and require minimal manipulation
to isolate. Further, demonstrating a kinotype within this
diverse and dynamic cell population would offer confi-
dence that individualized patterns of kinase activity would
also be observed in more static and homogenous tissues.
All human and porcine kinome profiles were analyzed
simultaneously using hierarchical clustering. There were
significant differences in the profiles of humans and pigs,
with nearly perfect species-specific separation of the
samples (Figure 1a). Specifically, at the highest level of
clustering, the samples separated into sample H2A (the
first time point sample of human subject A) and all other
samples (perhaps indicating that H2A was an outlier, as
all the remaining samples for human subject A clustered
exclusively with the other human samples). At the subse-
quent level, all remaining samples clustered into distinct,
species-specific groups. To calculate the extent to which
the samples clustered on the basis of species, the scoring
metric T described in Methods was applied to the binary
tree form of the dendrogram. The value of T was 97.9 out
of 100, indicating near-perfect clustering by species.
To determine whether T was greater than what would
be expected by chance, the score was also calculated for
10,000 random trees. No random tree had a score >39.6
(Figure 1b), giving a P-value <0.0001. This supported the
existence of species-specific patterns of kinome activity
within human and porcine PBMCs.
Individual-specific human kinome profiles
Having demonstrated a species-specific kinotype, we
investigated whether individual-specific kinomic patterns
exist within members of the same species. The human
subjects were investigated first as they were considered to
be more likely to display significant individual differences
due to variability in age, gender, race and lifestyle.
Hierarchical clustering analysis revealed a clear trend for
samples from the same individual to cluster together
(Figure 2a). The score calculated for the corresponding
tree was T = 62.5. This score was not equaled or
exceeded by any of the 10,000 random trees, with the
highest random tree score being 54.2, and only 0.6% of
Figure 1 Clustering of human and porcine kinome profiles. (a) Hierarchical clustering of human and porcine kinome profiles. The distance
metric used was (1 – Pearson correlation), while McQuitty linkage was used as the linkage method. Rows correspond to probes (phosphorylation
targets), and columns correspond to samples. The first character of each sample label identifies the species (“H” for human and “P” for pig), the
second character identifies the individual from which the sample was taken, and the third indicates the time point. Colors indicate the
average (over 9 intra-array replicates) normalized phosphorylation intensity of each target, with red indicating increased phosphorylation
and green indicating decreased phosphorylation. The intensity of the color corresponds to the degree of increase or decrease [36].
(b) Distribution of random tree scores. The number of random trees having each random tree score is shown. For comparison, the
score of the actual tree shown in part A is 97.9.
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comparison again gave a P-value <0.0001, supporting the
hypothesis that individual-specific patterns of kinome
activity exist within human PBMCs. The results of the
clustering analysis were further verified using principal
component analysis (PCA). The values of the first three
principal components were calculated for each human
sample and a three-dimensional scatterplot was created
(Figure 2c). As with the hierarchical clustering, there wasa strong trend for the kinome profiles to segregate on the
basis of individual.
As PBMCs represent a mixed cell population, we assessed
whether unique ratios of myeloid or lymphocyte subsets
within an individual could be associated with particular
signalling patterns. There was minimal variance between
individuals with respect to the relative ratio of PBMCs over
time (Table 1). The polymononuclear cell counts for the
pigs and humans were within the normal ranges of 25-40%
Figure 2 Clustering of human kinome profiles. (a) Hierarchical clustering of human kinome profiles. For details, see the caption for Figure 1a.
(b) Distribution of random tree scores. For comparison, the score of the actual tree shown in part A is 62.5. (c) Three dimensional PCA. Individual
subjects (H1, H2, H3, H4, H5, and H6) are color-coded. (d) Correlation between PBMC composition and kinome profiles. The Euclidean
distance was calculated between each of the C (4,2) = 6 possible pairs of samples from the same individual both for cell counts (as given
in Table 1) and for kinome profile (average normalized intensity values for each peptide on the corresponding array). The six Euclidean
distances were then averaged for a given individual, giving a single number that represents the level of variation in either cell counts or
kinome profile for that individual.
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significant relationship between the white blood cell
population variance and signaling profile variance within
individuals (Figure 2d).
Previously, we demonstrated that monocytes purified
from different animals have distinct signaling profiles
[12,13]. Thus, the differences in cell signaling profiles
could reflect contributions from genetic, epigenetic or
environmental variables. Although samples were collected
weekly, profiles from the same individual tended to cluster
together, suggesting that kinomic profiles are stable (at least
over a one-month period) (Figure 2a). Over this time frame,
there would be considerable turnover of cells and kinases,
offering some perspective on the imprinting of kinomic
patterns within individuals. Several subjects displayed
considerable changes in individual cell populations through-
out the investigation; however, samples still clustered onthe basis of individual, further supporting the existence of
a stable kinotype.
Individual-specific porcine kinome profiles
Having demonstrated a stable, individual-specific kinome
profile within human PBMCs, the concept of the kinotype
was further challenged by considering the same cell popu-
lation taken from pigs. In contrast to the diversity in the
human subjects (gender, age, genetics, and lifestyle), the
porcine subjects were littermates (siblings) housed within
the same environment and sustained on the same diet.
Remarkably, hierarchical clustering analysis still dem-
onstrated a strong trend for the samples to cluster by
individual (T = 50) (Figure 3a). The highest random tree
score was also 50, which was achieved by a single tree
(Figure 3b). The P-value was thus 0.0001, supporting the
hypothesis that individual-specific kinotypes exist within
Table 1 Differential white blood cell counts
Human Pig
ID Lymphocytes Monocytes ID Lymphocytes Monocytes
H1A 34 10 P1A 55 12
H1B 29 10 P1B 62 1
H1C 35 9 P1C 56 5
H1D 31 6 P1D 78 5
H2A 36 7 P2A 52 8
H2B 37 9 P2B 41 10
H2C 35 2 P2C 64 1
H2D 25 5 P2D 81 8
H3A 59 3 P3A 61 4
H3B 55 5 P3B 68 3
H3C 57 4 P3C 54 5
H3D 54 6 P3D 71 2
H4A 31 7 P4A 50 7
H4B 16 6 P4B 56 5
H4C 40 4 P4C 68 4
H4D 31 5 P4D 65 4
H5A 35 7 P5A 59 7
H5B 37 6 P5B 55 4
H5C 26 8 P5C 67 7
H5D 23 8 P5D 88 5
H6A 27 8 P6A 60 4
H6B 30 6 P6B 69 0
H6C 46 5 P6C 63 3
H6D 38 6 P6D 64 5
The first character in the sample ID column is either “H” for human or “P” for
pig. The second character (e.g. “2” in “H2A”) identifies the individual from
which the sample was taken, while the third character (e.g. “A”) indicates the
time point.
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segregation on the basis of individual (Figure 3c). As with
humans, there was no significant relationship between
white blood cell population variance and kinome profile
variance within individuals (Figure 3d).
Species-specific differences in the kinotypes
Having demonstrated the existence of species-specific
kinome profiles of human and porcine PBMCs, we sought
to identify the phosphorylation events responsible for the
species-specific clustering as well as to characterize the
biological events associated with them. Given that the
human and porcine samples clustered separately, one
would expect many peptides to be differentially phos-
phorylated between the two species. This was indeed
the case: 119 of the 297 peptides exhibited significantly
increased phosphorylation in the human samples relative
to the porcine samples, while 120 peptides exhibited
significantly decreased phosphorylation. Because thesample size was large for each peptide (216 observations
per species), statistical significance did not necessarily
imply that the difference was large in magnitude: some
of the peptides with small P-values also had small fold-
change (FC) values. The P-values and FC values for all
peptides can be found in Additional file 3.
We have previously applied pathway over-representation
analysis (ORA) to kinome data to infer cellular responses
from the standpoint of signaling networks [23,24]. To
provide initial biological insight into the observed species-
specific kinotypes, here we used the Ingenuity Pathway
Analysis software suite to perform functional network
analysis, which provides information regarding the regula-
tion of broad biological networks that can encompass
multiple signaling pathways and cellular receptors. Dif-
ferentially modulated functional networks identified
from the comparison of the human and porcine profiles
are presented in Figure 4. Functions related to cellular
development, cell survival and death, and maintenance of
cellular functions were over-represented, with phosphory-
lated mitogen-activated protein kinase (MAPK)-, signal
transducer and activator of transcription (STAT)- and
nuclear factor kappa-light-chain-enhancer of activated
B cells (NFΚB)-regulated responses occupying central
nodes of the functional network that exhibited the most
significant change in modulation (Figure 4a). In addition,
phosphorylated transforming growth factor (TGF)-β
signaling pathway intermediates (including TGF-βRI and
multiple SMAD proteins) formed central components of
the functional network having the second-most significant
change in modulation (Figure 4b). Additional biological
verification and characterization of these kinotypic differ-
ences will be the subject of a subsequent study.
Individual-specific differences in the kinotypes
The individual-specific kinome profiles observed in pigs
and humans support the hypothesis that kinome profiling
may provide a mechanism to identify biomarkers associated
with particular traits. To determine which peptides were
responsible for distinguishing the kinome profiles of the
individuals of a given species, the standard deviation of
the normalized intensity values (averaged over 4 samples
per individual and 9 technical replicates per sample)
among the 6 individuals was calculated for each peptide
(Additional file 4). The standard deviations of the peptides
varied greatly; in human, for instance, the most variable
peptide (which corresponded to the protein HSP27) had
a standard deviation of 0.56, whereas the least variable
peptide (IKK-α) had a standard deviation of 0.04. The
range was similar in pig, with the most variable peptide
(IRAK4) having a standard deviation of 0.48 and the least
variable peptide (iNOS) having a standard deviation of
0.02. A moderate correlation (r = 0.39) was found between
the standard deviation of a given peptide’s response in
Figure 3 Clustering of porcine kinome profiles. (a) Hierarchical clustering of porcine kinome profiles. For details, see the caption for Figure 1a.
(b) Distribution of random tree scores. For comparison, the score of the actual tree shown in part A is 50. (c) Three dimensional PCA. Individual
subjects (P1, P2, P3, P4, P5, and P6) are color-coded. (d) Correlation between PBMC composition and kinome profiles. The procedure for generating this
figure is the same as for Figure 2d.
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response in pig, suggesting that there is some commonality
between the two species in terms of the variability of the
response of a given peptide among different individuals.
Discussion
Efforts to correlate phenotypes with biomolecular charac-
teristics (e.g. nucleotide/amino acid sequences; patterns of
expression/translation/modification) must often comprom-
ise between ease of technical application and biological
relevance [25,26]. While static descriptors such as gene
sequences are readily available, they often fail to capture
the dynamic interplay between biological variables. In
some situations, such as certain genetic disorders, the
consequences associated with changes to a single biomol-
ecule are sufficiently extreme to override this diversity.
In other situations, interplay within the population of
biomolecules may be of greater significance. These dif-
ferences likely arise due to multiple levels of redundancy
and plasticity that provide buffering for genetic differences,
but also reflect individual responses. In these situations, itis most appropriate to define cellular responses at a level
that reflects this interplay, ideally as close as possible to
the phenotype. The challenge here is that unlike genetic
polymorphisms, the levels of these biomolecules are
dynamic and may be unique to particular tissues, cells
or intracellular locations. From a practical perspective,
there is also the need to be able to reliably quantify
these biomolecules in a robust, cost-effective and high-
throughput manner.
Protein kinases play a central role in regulating biological
functions at the levels of proteins through to pathways and,
ultimately, phenotypes. Changes in activities of individual
kinases, through genetic defects or therapeutic modulation,
can have profound impacts on the health and viability of
an organism [27]. The growing interest in kinases in
both basic and translational research has driven efforts
to develop technologies that enable characterization of
phosphorylation-mediated signal transduction [11,28].
Kinome analysis offers three key advantages over traditional
gene and protein profiling: 1) individual kinase activities are
often reliable indictors of phenotypic changes, 2) kinase
Figure 4 Functional network analysis of differentially modulated kinome responses in humans as compared to pigs. Peptide
fold-change values for humans as compared to pigs were uploaded to IPA for functional network analysis. Differentially modulated functions
were identified as follows: (a) cellular development, cell death and survival, cellular function and maintenance; and (b) gene expression, digestive
system development and function, cell death and survival. As in the heatmaps, red indicates increased phosphorylation and green indicates
decreased phosphorylation.
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level of signalling pathways, and 3) as kinases are highly
“druggable” [8,9], increased understanding of the bio-
logical role for kinases could aid therapeutic design
and development.
To this end, our investigation sought to examine kinome
responses in both inter- and intra-species comparatives.
Our results demonstrate the existence of temporally stable
species- and individual-specific kinotypes. Hierarchical
clustering of the kinome data derived from human and
porcine PBMCs showed that the kinome profiles clustered
in a species-specific manner, suggesting that kinotype
analysis could provide critical information regarding cell
processes or signalling pathways that are differentially
modulated across similar animal species.
In addition to verifying the existence of species-specific
kinotypes, this finding may have further implications and
applications. Recently, Seok and colleagues reported on
the disparate correlation in genomic responses between
human inflammatory diseases and murine inflammatory
models [1]. This highlights a problem in basic and transla-
tional research where animal models of disease are largely
validated through phenotypic similarity to human disease.
Our results suggest that kinome analysis could be beneficial
for the evaluation and assessment of animal models. In-
deed, pigs are often employed as animal models of human
disease. Thus, understanding the biological differences orpredispositions between pigs and humans could inform
situations where pigs may represent an appropriate animal
model as well as influence the interpretation of emerging
results. Further, our demonstration of species-specific
kinotypes suggests that kinotype analysis could provide
critical information regarding the degree of conservation
of essential cell processes across animal species, in particu-
lar those that are closely related. Further, we postulate
that kinome analysis could provide information regarding
conserved mechanisms of molecular pathogenesis between
humans and animals routinely used in models of human
malignancies. With respect to the current US Food and
Drug Administration Animal Efficacy Rule [29,30], kinome
analysis could provide insight in investigations for which
human efficacy trials are neither feasible nor ethical and,
in particular, in the selection of animal models that best
recapitulate human molecular disease.
From the standpoint of drug development, the analysis
of individual-specific kinotypes could help define the
temporal stability of particular drug targets as well as
their conservation across the population. Personalized
medicine is based on an appreciation that natural biological
variation exists within outbred populations. Customizing
diagnoses and therapies to an individual rather than an
assumed biological norm has the potential to maximize
treatment efficacy while minimizing side effects [31,32]. The
implementation of personalized medicine at a molecular
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accurately predict some aspect of disease, such as onset,
prognosis or treatment efficacy. It is our belief that
kinotype analysis could facilitate this process.
Beyond this study, there is a substantial opportunity
for future work in terms of expanding the number of
model organisms considered. Perhaps the most important
information that could be derived from an analysis involv-
ing several species would be to determine which has a
kinome profile most similar to that of human. More
generally, it would be interesting to compare the clustering
of the different species’ kinome profiles with those obtained
from traditional sequence-based phylogenetic approaches
(e.g. mitochondrial 16S rRNA gene comparisons). An-
swering the question, “Is there a strong relationship be-
tween genetic similarity and kinotypic similarity?” would
be hugely beneficial in terms of selecting appropriate
animal models and understanding how well the responses
of a given model might reflect those in human. Another
avenue for future work derives from the fact that the
number of samples could become quite large if several
species are considered, especially if many individuals are
tested per species and/or many samples are taken per
individual. In this study, four samples were taken from
each of six individuals from each of two species, for a total
of 48 samples. In addition, each sample was exposed to
a peptide array with nine intra-array technical replicates
per peptide sequence. Kinome microarrays are relatively
inexpensive; nonetheless, in order to provide accurate
comparisons while simultaneously minimizing costs, it
could be beneficial to characterize the number of intra-
array replicates per sample, samples per individual, and
individuals per species required to accurately reflect the
level of kinotypic similarity among species and individuals.
Conclusions
The identification of phosphorylation signatures associated
with disease states using kinome analysis may become an
important tool in basic and translational research. This
study suggests that these signatures must be considered
in the context of the range of variability at the level of
both species and individual. For instance, if an animal is
being considered as a model for a particular disease—and
in particular, if host responses are being evaluated at the
kinome level—then species-specific baseline levels of
kinase activity may need to be taken into account. The
same concept applies in the context of personalized
medicine: a treatment that is effective in some individuals
may not be effective in other individuals, and it is possible
that an individual’s kinome profile may be predictive of
the efficacy of a given treatment. Of course, further studies
are needed to precisely define the methodology needed for
incorporating kinome analysis into both treatment studies
and studies involving animal models. While consideringbaseline kinomic responses may prove complicated, the
discovery of complex biomarkers, in particular those
associated with kinase activities, has tremendous potential




Human and porcine blood samples were collected weekly
for 4 consecutive weeks. For humans, 6 unrelated individ-
uals (3 male and 3 female) diverse in age (21–55), race,
diet, and health status were selected. Porcine samples were
obtained from 6 littermates (3 male and 3 female) begin-
ning at 4 weeks of age. Pigs were housed within the same
pen and fed the same diet. Bleeds were performed at the
same time each day to minimize variability associated with
circadian rhythms and postprandial effects. PBMCs were
isolated as previously described [33]. Aliquots of 1 × 107
PBMCs were snap-frozen in liquid N2 and stored at −80°C
for kinome analysis. All animal procedures were performed
in accordance with the standards of the Canadian Council
on Animal Care. Human subjects provided written in-
formed consent before participation. This procedure,
and all research done using these samples, was done in
accordance with the University of Saskatchewan Clinical
Research Ethics Board.
Peptide arrays
Design, construction and application of the peptide arrays
were based on previous protocols with modifications [34].
A commercial provider, JPT Peptide Technologies (http://
www.jpt.com), was contracted to fabricate the arrays.
Peptides from proteins representing a wide variety of
signalling pathways were included on the arrays. Specific-
ally, 297 peptide sequences were chosen, each of which
was spotted 9 times on the same array (i.e. there were 9
intra-array technical replicates per peptide). It should be
noted that this type of technical replicate is distinct from
inter-array technical replicates, for which the entire process
(from incubation of the sample with the array to scanning
the array using image analysis software) is repeated
multiple times. The technical replicates for a given peptide
were averaged prior to performing clustering analysis. The
exact composition of the array, including spot coordinates,
block layouts, and peptide sequences, is given in Additional
file 5.
All peptides on the array are found as exact matches
in both the human proteome and the porcine proteome; as
such, the same arrays were used for both species, enabling
a direct comparison of all kinome profiles. Kinome array
experiments for both species were performed on the same
day to minimize technical variance and performed as
described previously [35]. Each resulting dataset contained
the signal intensities associated with all 9 replicates of the
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All data processing and analysis was done using the
Platform for Intelligent, Integrated Kinome Analysis
(PIIKA) software [36], which is freely available for non-
commercial use at http://saphire.usask.ca/saphire/piika.
Evidence for individual kinotypes in humans and pigs
To determine whether unique kinotypes existed within
individuals, the following statistical question was addressed:
“Do samples from the same individual cluster more closely
than expected by chance?” Samples from the 6 individual
humans and pigs were separately subjected to hierarchical
clustering using (1 – Pearson correlation) as the distance
metric and McQuitty linkage as the linkage method. We
defined a metric describing how close to perfect (i.e. all
samples from the same individual clustering together) the
actual clustering was. As each iteration of the hierarchical
clustering algorithm results in a bifurcation, the resulting
dendrogram can be represented as a binary tree wherein
each leaf represents one of the 24 samples, and each
internal node represents a cluster of 2 or more samples.
For each individual i, a score si was computed. If some
internal node in the binary tree had, as descendants, four
leaves corresponding to individual i and none corresponding
to any other individual, then si = 4. If the same criteria
could be satisfied but with only 3 leaves corresponding to
individual i, then si = 3, and similarly for si = 2 and si = 1. If
there were no internal nodes having, as descendants, only
leaves corresponding to individual i, then si = 0.
The score for the entire tree was S ¼
X6
i¼1s1 , with the
maximum possible score being 24. This was then expressed
as a score out of 100: T= S / 24 × 100. To determine
whether T was greater than would be expected by chance,
an empirical statistical distribution was derived by gener-
ating 10,000 random trees. Each tree was created by
randomly rearranging the normalized intensity values
for the peptides within a given sample. The average nor-
malized intensity value (over the 9 technical replicates) for
a given peptide X was randomly assigned to a different
peptide Y from the same sample, and this was done for
all peptides across all samples. For each random tree j,
hierarchical clustering was performed and a score Tj was
calculated as described above. The P-value for a given
score T was then calculated as the proportion of scores Tj
that were ≥ T.
Evidence for species-specific kinotypes
To answer the question, “Do samples from the same
species cluster more closely than expected by chance?”,
hierarchical clustering was performed with all samples
from both species at once. The same scoring metric as
above was used, but with only 2 “individuals” – human and
pig, each with 24 samples. Thus, S ¼ ∑2i¼1s1, with s1 and s2denoting the scores for the human and porcine samples,
respectively, and T = S / 48 × 100. Statistical significance
was determined as above.Correlating cell composition and kinome profiles
Blood contains a dynamic population of cells that, based
on their unique functions, likely exhibit distinct signalling
activity. Thus, species- or individual-specific kinome
patterns could reflect unique blood cell populations.
To account for this potential variability, differential
counts were performed on each sample. Importantly,
kinome analysis was performed solely on PBMCs (lympho-
cytes and monocytes) and excluded polymononuclear cells
(PMNs). We investigated whether there was any correlation
between kinome profiles and relative abundance of PBMCs
as follows.
The level of variability within an individual’s kinome
profile over time was determined by finding the Euclidean
distance between each of the 6 possible pairs of samples
for the same individual (week 1 and week 2, week 1 and
week 3, etc.) with respect to the average normalized
intensities for each peptide. Specifically, each sample
was represented as a vector of length 297, where each
element represented the average normalized intensity
value for a peptide on the array. For a given pair of




. The level of variability in a given individ-
ual’s kinome profile was the average of all 6 Euclidean
distances. The level of variability in cell counts over
time was assessed similarly, except the values of a given
vector represented counts for a given cell type. As such,
these vectors were of length 2 (lymphocytes and mono-
cytes). To determine whether there was a relationship
between the variables mentioned above, a scatterplot was
created for each species wherein the independent axis
represented variability in cell counts for a given individual,
and the dependent axis represented variability in kinome
profile. Linear regression was performed, and the coeffi-
cients of the regression line and the R2 value were cal-
culated for each species.Species-specific differences in the kinotypes
Statistical tests for identifying peptides differentially
phosphorylated in the human samples compared to the
porcine samples were carried out as described previously
[36]. Specifically, for each peptide, a t-test was done by
comparing all 216 human observations (6 subjects × 4
samples per subject × 9 technical replicates per sample)
against all 216 porcine observations. A peptide was
considered to be differentially phosphorylated if the result-
ing P-value was less than 0.05. Pathway overrepresentation
analysis was performed as previously described [36], except
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Individual-specific differences in the kinotypes
In order to identify peptides driving the differences between
the kinome profiles of different individuals, the 36 normal-
ized intensity values for a given individual (4 samples
per individual × 9 technical replicates per sample) were
averaged for each peptide. Within each species, the
standard deviation of these values for the 6 individuals
was calculated. Peptides with high standard deviation had
the greatest variation in responses among the individuals,
while peptides with low standard deviation had the most
consistent responses.
Additional files
Additional file 1: Raw array intensity data for all human and
porcine samples. Columns correspond to samples and rows correspond
to peptides. The rows are in groups of 9, representing the values for the
9 technical replicates associated with a given peptide. The first column
for a given sample represents the foreground intensity, while the second
column represents the background intensity.
Additional file 2: Intensity data after background subtraction and
normalization. Columns correspond to samples and rows correspond to
peptides. Unlike Additional file 1, there is only one row corresponding to a
given peptide; however, there are 9 columns for each array, which give the
normalized intensity values for the 9 technical replicates for that peptide.
Additional file 3: Comparison of human and porcine kinome
responses. The fold-change value between human and pig is given for
each peptide on the array, along with P-values for increased and decreased
phosphorylation.
Additional file 4: Inter-individual variability of peptide responses.
The left-hand block of cells contain, for a given peptide and individual,
the mean normalized intensity value among the 36 observations (4 samples
per individual and 9 technical replicates per sample). Column O contains
the standard deviation of the 6 human means, while column R contains the
standard deviation of the 6 porcine means.
Additional file 5: Composition of the peptide arrays. This GenePix
Array List (GAL) file contains the exact composition of the peptide array
used in this study, including the location of each spot and the peptide
contained in that spot. It is in plain-text format and can thus be read by
any text editor.
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